Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Tennessee Hemophilia and Bleeding Disorder Foundation (THBDF) is a non-profit organization dedicated to improving the quality of life for individuals and families affected by bleeding disorders in Tennessee. Established in 1991, the foundation provides essential education, advocacy, and support services for conditions such as hemophilia and von Willebrand disease. THBDF collaborates with Hemophilia Treatment Centers and healthcare providers to ensure patients have access to necessary resources and specialized care. Through community events, educational seminars, and financial assistance programs, the organization fosters a supportive network for the rare disease community. The foundation also engages in legislative advocacy to protect the rights and healthcare access of those with chronic bleeding conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tennessee Hemophilia and Bleeding Disorder Foundation.